This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Sera Prognostics, Inc.. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Chad Bradford: Innovator in Preterm Birth Prediction
Introduction
Chad Bradford is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of biomedical research, particularly in the area of predicting preterm birth. With a total of 3 patents to his name, Bradford's work is paving the way for advancements in maternal health.
Latest Patents
One of Bradford's latest patents focuses on biomarker pairs for predicting preterm birth. This patent discloses a pair of isolated biomarkers selected from a specific group, including IBP4/SHBG, IBP4/PSG3, and others. The biomarkers exhibit a change in reversal value between pregnant females at risk for preterm birth and term controls. The patent also outlines a method for determining the probability of preterm birth in a pregnant female by measuring the reversal value for at least one pair of these biomarkers in a biological sample.
Career Highlights
Chad Bradford is currently associated with Sera Prognostics, Inc., where he continues to innovate in the field of predictive biomarkers. His work is crucial in developing methods that can potentially save lives by identifying at-risk pregnancies early.
Collaborations
Bradford collaborates with esteemed colleagues such as Ashoka Dharmapriya Polpitiya and Gregory Charles Critchfield. Their combined expertise enhances the research and development efforts at Sera Prognostics, Inc.
Conclusion
Chad Bradford's contributions to the field of preterm birth prediction through his innovative patents and collaborations are making a significant impact on maternal health. His work exemplifies the importance of research and innovation in addressing critical health challenges.